Guizhou Salvage Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
April 22, 2022 at 08:11 am EDT
Share
Guizhou Salvage Pharmaceutical Co.,Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 2,075.21 million compared to CNY 1,854.71 million a year ago. Revenue was CNY 2,181.37 million compared to CNY 1,926.85 million a year ago. Net loss was CNY 51.87 million compared to net income of CNY 55.61 million a year ago. Basic loss per share from continuing operations was CNY 0.0306 compared to basic earnings per share from continuing operations of CNY 0.0328 a year ago. Diluted loss per share from continuing operations was CNY 0.0306 compared to diluted earnings per share from continuing operations of CNY 0.0328 a year ago.
Guizhou Chitianhua Co Ltd, formerly Guizhou Salvage Pharmaceutical Co Ltd, is a China-based company mainly engaged in chemical production and pharmaceutical production. The chemical business mainly includes the production and sales of urea, methanol and compound fertilizer. The pharmaceutical manufacturing business mainly includes the production and sales of pharmaceuticals and medical devices. The Company's pharmaceutical products include diabetes drugs, cardiovascular drugs, dermatology drugs, gynecological drugs, digestive system drugs, endocrine drugs, psychotropic drugs, among others. The Company mainly conducts businesses within the domestic market.